PDB Short entry for 2GEG HEADER OXIDOREDUCTASE 20-MAR-06 2GEG TITLE THEORETICAL MODEL OF HUMAN CYP21 (CYTOCHROME P450, 21- TITLE 2 HYDROXYLASE) BASED ON RABBIT CYP2C5. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450 XXI; COMPND 3 CHAIN: C; COMPND 4 SYNONYM: STEROID 21-HYDROXYLASE; 21- OHASE; P450-C21; P- COMPND 5 450C21; P450-C21B; COMPND 6 EC: 1.14.99.10 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN KEYWDS CAH; CONGENITAL ADRENAL HYPERPLASIA EXPDTA THEORETICAL MODEL AUTHOR T.ROBINS,J.CARLSSON,M.SUNNERHAGEN,A.WEDELL,B.PERSSON REVDAT 2 28-NOV-06 2GEG 1 JRNL REVDAT 1 19-SEP-06 2GEG 0 JRNL AUTH T.ROBINS,J.CARLSSON,M.SUNNERHAGEN,A.WEDELL, JRNL AUTH 2 B.PERSSON JRNL TITL MOLECULAR MODEL OF HUMAN CYP21 BASED ON MAMMALIAN JRNL TITL 2 CYP2C5: STRUCTURAL FEATURES CORRELATE WITH JRNL TITL 3 CLINICAL SEVERITY OF MUTATIONS CAUSING CONGENITAL JRNL TITL 4 ADRENAL HYPERPLASIA JRNL REF MOL.ENDOCRINOL. V. 20 2946 2006 JRNL REFN ASTM MOENEN US ISSN 0888-8809 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GEG COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PRAGUE ON 06-APR-2006. REMARK 100 THE RCSB ID CODE IS RCSB037017. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: MINIMIZED BY PROGRAM ICM 3.2, ICM MOLSOFT L.L.C.BY REMARK 220 R.ABAGYAN, M.TOTROV REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER C 73 155.31 74.12 REMARK 500 SER C 374 -96.17 49.91 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO C 34 GLY C 35 -149.70 REMARK 500 TYR C 104 PRO C 105 -98.25 REMARK 500 VAL C 334 PRO C 335 -52.74 REMARK 500 ALA C 362 LEU C 363 141.10 DBREF 2GEG C 27 494 UNP P08686 CP21A_HUMAN 27 494 SEQRES 1 C 468 LEU HIS LEU PRO PRO LEU ALA PRO GLY PHE LEU HIS LEU SEQRES 2 C 468 LEU GLN PRO ASP LEU PRO ILE TYR LEU LEU GLY LEU THR SEQRES 3 C 468 GLN LYS PHE GLY PRO ILE TYR ARG LEU HIS LEU GLY LEU SEQRES 4 C 468 GLN ASP VAL VAL VAL LEU ASN SER LYS ARG THR ILE GLU SEQRES 5 C 468 GLU ALA MET VAL LYS LYS TRP ALA ASP PHE ALA GLY ARG SEQRES 6 C 468 PRO GLU PRO LEU THR TYR LYS LEU VAL SER LYS ASN TYR SEQRES 7 C 468 PRO ASP LEU SER LEU GLY ASP TYR SER LEU LEU TRP LYS SEQRES 8 C 468 ALA HIS LYS LYS LEU THR ARG SER ALA LEU LEU LEU GLY SEQRES 9 C 468 ILE ARG ASP SER MET GLU PRO VAL VAL GLU GLN LEU THR SEQRES 10 C 468 GLN GLU PHE CYS GLU ARG MET ARG ALA GLN PRO GLY THR SEQRES 11 C 468 PRO VAL ALA ILE GLU GLU GLU PHE SER LEU LEU THR CYS SEQRES 12 C 468 SER ILE ILE CYS TYR LEU THR PHE GLY ASP LYS ILE LYS SEQRES 13 C 468 ASP ASP ASN LEU MET PRO ALA TYR TYR LYS CYS ILE GLN SEQRES 14 C 468 GLU VAL LEU LYS THR TRP SER HIS TRP SER ILE GLN ILE SEQRES 15 C 468 VAL ASP VAL ILE PRO PHE LEU ARG PHE PHE PRO ASN PRO SEQRES 16 C 468 GLY LEU ARG ARG LEU LYS GLN ALA ILE GLU LYS ARG ASP SEQRES 17 C 468 HIS ILE VAL GLU MET GLN LEU ARG GLN HIS LYS GLU SER SEQRES 18 C 468 LEU VAL ALA GLY GLN TRP ARG ASP MET MET ASP TYR MET SEQRES 19 C 468 LEU GLN GLY VAL ALA GLN PRO SER MET GLU GLU GLY SER SEQRES 20 C 468 GLY GLN LEU LEU GLU GLY HIS VAL HIS MET ALA ALA VAL SEQRES 21 C 468 ASP LEU LEU ILE GLY GLY THR GLU THR THR ALA ASN THR SEQRES 22 C 468 LEU SER TRP ALA VAL VAL PHE LEU LEU HIS HIS PRO GLU SEQRES 23 C 468 ILE GLN GLN ARG LEU GLN GLU GLU LEU ASP HIS GLU LEU SEQRES 24 C 468 GLY PRO GLY ALA SER SER SER ARG VAL PRO TYR LYS ASP SEQRES 25 C 468 ARG ALA ARG LEU PRO LEU LEU ASN ALA THR ILE ALA GLU SEQRES 26 C 468 VAL LEU ARG LEU ARG PRO VAL VAL PRO LEU ALA LEU PRO SEQRES 27 C 468 HIS ARG THR THR ARG PRO SER SER ILE SER GLY TYR ASP SEQRES 28 C 468 ILE PRO GLU GLY THR VAL ILE ILE PRO ASN LEU GLN GLY SEQRES 29 C 468 ALA HIS LEU ASP GLU THR VAL TRP GLU ARG PRO HIS GLU SEQRES 30 C 468 PHE TRP PRO ASP ARG PHE LEU GLU PRO GLY LYS ASN SER SEQRES 31 C 468 ARG ALA LEU ALA PHE GLY CYS GLY ALA ARG VAL CYS LEU SEQRES 32 C 468 GLY GLU PRO LEU ALA ARG LEU GLU LEU PHE VAL VAL LEU SEQRES 33 C 468 THR ARG LEU LEU GLN ALA PHE THR LEU LEU PRO SER GLY SEQRES 34 C 468 ASP ALA LEU PRO SER LEU GLN PRO LEU PRO HIS CYS SER SEQRES 35 C 468 VAL ILE LEU LYS MET GLN PRO PHE GLN VAL ARG LEU GLN SEQRES 36 C 468 PRO ARG GLY MET GLY ALA HIS SER PRO GLY GLN ASN GLN HET HEM C 500 43 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN HEM HEME FORMUL 2 HEM C34 H32 FE N4 O4 HELIX 1 1 LEU C 44 PHE C 55 1 12 HELIX 2 2 ASN C 72 VAL C 82 1 11 HELIX 3 3 PRO C 94 LYS C 102 1 9 HELIX 4 4 TYR C 112 LEU C 128 1 17 HELIX 5 5 SER C 134 GLN C 153 1 20 HELIX 6 6 ILE C 160 GLY C 178 1 19 HELIX 7 7 PRO C 188 LEU C 198 1 11 HELIX 8 8 ILE C 206 VAL C 211 1 6 HELIX 9 9 PHE C 218 GLU C 238 1 21 HELIX 10 10 LEU C 241 SER C 247 1 7 HELIX 11 11 ASP C 255 GLN C 266 1 12 HELIX 12 12 LEU C 277 HIS C 310 1 34 HELIX 13 13 HIS C 310 LEU C 325 1 16 HELIX 14 14 TYR C 336 ARG C 341 1 6 HELIX 15 15 LEU C 342 ARG C 356 1 15 HELIX 16 16 ASN C 387 LEU C 393 1 7 HELIX 17 17 TRP C 405 LEU C 410 5 6 HELIX 18 18 CYS C 423 VAL C 427 5 5 HELIX 19 19 GLY C 430 ALA C 448 1 19 HELIX 20 20 LEU C 452 ASP C 456 5 5 SHEET 1 A 4 ILE C 58 HIS C 62 0 SHEET 2 A 4 ASP C 67 LEU C 71 -1 O VAL C 68 N LEU C 61 SHEET 3 A 4 VAL C 383 PRO C 386 1 O VAL C 383 N VAL C 69 SHEET 4 A 4 HIS C 365 ARG C 366 -1 N HIS C 365 O ILE C 384 SHEET 1 B 2 SER C 371 ILE C 373 0 SHEET 2 B 2 TYR C 376 ILE C 378 -1 O ILE C 378 N SER C 371 SHEET 1 C 2 PHE C 449 THR C 450 0 SHEET 2 C 2 GLN C 481 PRO C 482 -1 O GLN C 481 N THR C 450 SSBOND 1 CYS C 169 CYS C 173 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000